Evidence map›Paper›PMID 38977918›Full record

ArticleMolecular psychiatry2025

DNA methylation profiles of cancer-related fatigue associated with markers of inflammation and immunometabolism.

Canhua Xiao, Gang Peng, Karen N Conneely, Hongyu Zhao, Jennifer C Felger, Evanthia C Wommack, Kristin A Higgins, Dong M Shin, Nabil F Saba, Deborah W Bruner and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Canhua Xiao *Emory University School of Nursing, Atlanta, GA, USA. canhua.xiao@emory.edu.ORCID 0000-0003-1391-5325
Gang Peng *Indianan University School of Medicine, Department of Medical and Molecular Genetics, Indianapolis, IN, USA.
Karen N ConneelyEmory University School of Medicine, Department of Human Genetics, Atlanta, GA, USA.ORCID 0000-0002-1994-6934
Hongyu ZhaoYale University School of Medicine, Department of Genetics, New Haven, CT, USA.ORCID 0000-0003-1195-9607
Jennifer C FelgerEmory University School of Medicine, Department of Psychiatry and Behavioral Sciences, Atlanta, GA, USA.ORCID 0000-0003-4354-2267
Evanthia C WommackEmory University School of Medicine, Department of Psychiatry and Behavioral Sciences, Atlanta, GA, USA.
Kristin A HigginsEmory University School of Medicine, Department of Radiation Oncology, Atlanta, GA, USA.
Dong M ShinEmory University School of Medicine, Department of Hematology and Medical Oncology, Atlanta, GA, USA.
Nabil F SabaEmory University School of Medicine, Department of Hematology and Medical Oncology, Atlanta, GA, USA.
Deborah W BrunerEmory University School of Nursing, Atlanta, GA, USA.
Andrew H MillerEmory University School of Medicine, Department of Psychiatry and Behavioral Sciences, Atlanta, GA, USA.ORCID 0000-0001-8260-7997

Funding

Winship Cancer Institute Cancer Center Support GrantP30CA138292 · NCI · EMORY UNIVERSITY · PI Suresh S Ramalingam · 2009 to 2026
$47.5M
Biological and social determinants of psychosocial sequelae in advanced head and neck cancer survivors receiving immunotherapyR01CA281873 · NCI · EMORY UNIVERSITY · PI Veronika Fedirko, Canhua Xiao · 2024 to 2026
$2.0M
Epigenetic Mechanisms of Inflammation and Fatigue in Head and Neck Cancer PatientsR01NR015783 · NINR · EMORY UNIVERSITY · PI XIAO, CANHUA · 2016 to 2018
$1.5M
Fatigue in Head and Neck Cancer: Role of pro- and anti-inflammatory signalingR00NR014587 · NINR · EMORY UNIVERSITY · PI XIAO, CANHUA · 2015 to 2017
$706k
Fatigue in Head and Neck Cancer: Role of pro- and anti-inflammatory signalingK99NR014587 · NINR · EMORY UNIVERSITY · PI XIAO, CANHUA · 2013 to 2014
$180k
NCI NIH HHS P30 CA138292NCI NIH HHS R01 CA281873NINR NIH HHS K99 NR014587NINR NIH HHS R00 NR014587NINR NIH HHS R01 NR015783U.S. Department of Health & Human Services | NIH | National Institute of Nursing Research (NINR) K99NR014587U.S. Department of Health & Human Services | NIH | National Institute of Nursing Research (NINR) R00NR014587U.S. Department of Health & Human Services | NIH | National Institute of Nursing Research (NINR) R01NR015783
6 · The paper itself

Abstract

Cancer patients are commonly affected by fatigue. Herein, we sought to examine epigenetic modifications (i.e., DNA methylation) related to fatigue in peripheral blood among patients during and after treatment for head and neck cancer (HNC). Further, we determined whether these modifications were associated with gene expression and inflammatory protein markers, which we have previously linked to fatigue in HNC. This prospective, longitudinal study enrolled eligible patients with data collected at pre-radiotherapy, end of radiotherapy, and six months and one-year post-radiotherapy. Fatigue data were reported by patients using the Multidimensional Fatigue Inventory (MFI)-20. DNA methylation (Illumina MethylationEPIC) and gene expression (Applied Biosystems Clariom S) arrays and assays for seven inflammatory markers (R&D Systems multiplex) were performed. Mixed models and enrichment analyses were applied to establish the associations. A total of 386 methylation loci were associated with fatigue among 145 patients (False Discovery Rate [FDR] < 0.05). Enrichment analyses showed the involvement of genes related to immune and inflammatory responses, insulin and lipid metabolism, neuropsychological disorders, and tumors. We further identified 16 methylation-gene expression pairs (FDR < 0.05), which were linked to immune and inflammatory responses and lipid metabolism. Ninety-one percent (351) of the 386 methylation loci were also significantly associated with inflammatory markers (e.g., interleukin 6, c-reactive protein; FDR < 0.05), which further mediated the association between methylation and fatigue (FDR < 0.05). These data suggest that epigenetic modifications associated with inflammation and immunometabolism, in conjunction with relevant gene expression and protein markers, are potential targets for treating fatigue in HNC patients. The findings also merit future prospective studies in other cancer populations as well as interventional investigations.

Indexed as

DNA MethylationEpigenesis, GeneticFatigueInflammationAdultAgedBiomarkersFemaleHead and Neck NeoplasmsHumansLongitudinal StudiesMaleMiddle AgedNeoplasmsProspective StudiesBiomarkers

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.